Extracellular matrix formation reduction by nintedanib varies in the Scar-in-a-Jar fibroblast model depending on pathway induction

M. Christensen (Copenhagen, Denmark), P. Juhl (Copenhagen, Denmark), D. Leeming (Copenhagen, Denmark), J. Sand (Copenhagen, Denmark)

Source: International Congress 2022 – Identifying therapeutic targets and novel drug strategies in pulmonary diseases

Session: Identifying therapeutic targets and novel drug strategies in pulmonary diseases
Session type: Thematic Poster
Number: 2834

Rating:

You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
M. Christensen (Copenhagen, Denmark), P. Juhl (Copenhagen, Denmark), D. Leeming (Copenhagen, Denmark), J. Sand (Copenhagen, Denmark). Extracellular matrix formation reduction by nintedanib varies in the Scar-in-a-Jar fibroblast model depending on pathway induction. 2834

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.

You must Login to comment this presentation.